Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profusa (PFSA) Liabilities and Shareholders Equity (2023 - 2025)

Profusa filings provide 3 years of Liabilities and Shareholders Equity readings, the most recent being $3.8 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 22.84% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.0 million, a 58.64% decrease, with the full-year FY2025 number at $3.8 million, up 22.84% from a year prior.
  • Liabilities and Shareholders Equity hit $3.8 million in Q4 2025 for Profusa, down from $4.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $10.9 million in Q4 2023 to a low of $2.0 million in Q2 2025.
  • Median Liabilities and Shareholders Equity over the past 3 years was $4.2 million (2025), compared with a mean of $5.8 million.
  • The widest YoY moves for Liabilities and Shareholders Equity: up 22.84% in 2025, down 77.15% in 2025.
  • Profusa's Liabilities and Shareholders Equity stood at $10.9 million in 2023, then tumbled by 71.77% to $3.1 million in 2024, then increased by 22.84% to $3.8 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $3.8 million (Q4 2025), $4.2 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.